25 April 2022 - Late-stage breast cancer patients, many of them young women, will have access to a life-extending medication when it is added to the Pharmaceutical Benefits Scheme on Sunday.

The drug Trodelvy will be added to the scheme on May 1, giving up to 800 Australians with rare and aggressive triple-­negative breast cancer precious time with loved ones and saving them up to $80,000 a treatment.

Read The Australian article